Moolec Science (MLECW) Change in Acquisitions & Divestments (2023 - 2024)

Moolec Science (MLECW) posted Change in Acquisitions & Divestments of -$432386.0 for Q1 2024, down 4975.8% sequentially from $8868.0 in Q4 2023.

Moolec Science (MLECW) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends

Moolec Science has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at -$432386.0 in Q1 2024.

Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to -$432386.0 in Q1 2024, while the trailing twelve-month figure through Jun 2024 was -$144514.0 (changed N/A YoY) and the FY2024 annual result came in at -$144514.0, up 94.38% from the prior year.
Change in Acquisitions & Divestments slipped to -$432386.0 in Q1 2024 per MLECW's latest filing, from $8868.0 in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $279004.0 in Q3 2023 and troughed at -$432386.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Moolec Science	8,617.72	-1.19 Mn	-

Download Data